DCF — UNIVERSITY OF WASHINGTON MED CTR
Enterprise Value: $-4.4B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-4.4B
Enterprise Value
$-1.4B
PV of Cash Flows
$-3.1B
PV of Terminal Value
$-4.9B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.1B | $-288.9M | -14.0% | $-376.8M | $-342.6M |
| Year 2 | $2.1B | $-276.1M | -13.0% | $-366.7M | $-303.1M |
| Year 3 | $2.2B | $-262.4M | -12.0% | $-355.7M | $-267.2M |
| Year 4 | $2.3B | $-258.9M | -11.0% | $-355.0M | $-242.5M |
| Year 5 | $2.3B | $-260.8M | -11.0% | $-359.8M | $-223.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-4.4B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.0B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14404446671302928
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5